================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
----------------------------------------------------------------------
Date of Report (Date of earliest event reported): June 15, 2005
DOBI MEDICAL INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-32523 98-0222710
- ---------------------------- ------------------------ -------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
1200 MacArthur Boulevard 07430
Mahwah, New Jersey ---------
---------------------------------------- (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (201) 760-6464
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
1
ITEM 8.01 OTHER EVENTS.
In our Quarterly Report on Form 10-QSB filed on May 26, 2005, we stated
that we were currently on target to release version 2.0 of our ComfortScan(TM)
system in the second quarter of 2005, although there could be no assurance that
we would do so.
We have recently completed internal testing of our 2.0 ComfortView(TM)
reading software and have determined that the results did not meet our
expectations. Therefore, we will not be releasing version 2.0 of our ComfortScan
system as expected by the end of June 2005. At this time, we are not projecting
when it will be released.
We are continuing to acquire scans at our PMA clinical sites and to
bring on additional PMA clinical sites as we seek to submit PMA results to the
FDA by the end of December 2005. However, there can be no assurance that we will
do so.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DOBI MEDICAL INTERNATIONAL, INC.
Date: June 15, 2005 By:/s/Phillip C. Thomas
-----------------------------
Phillip C. Thomas
Chief Executive Officer
2